Navigation Links
Med Ad News Honors Roche as 'Company of the Year'
Date:10/1/2007

ut Roche

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system. In 2006, sales by the Pharmaceuticals Division totaled 33.3 billion Swiss francs ($26.6 billion US), and the Diagnostics Division posted sales of 8.7 billion Swiss francs ($6.96 billion US). Roche has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invests approximately 7 billion Swiss francs ($5.6 billion) a year in R&D. Worldwide, the Group employs about 75,000 people. Additional information on Roche is available at http://www.roche.com or http://www.rocheusa.com.


'/>"/>
SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Eau Claire business contest honors tech start ups
2. Group honors UW-Madisons Stunden for IT leadership
3. Annual Conference Honors Tech Grant Winners
4. Advantages of Roche Applied Science amplification products
5. Roche Diagnostics Corporation
6. Roche Diagnostics Corporation
7. NimbleGen to discontinue IPO after Roches $272.5 million acquisition
8. Prodesse enters patent agreement with Roche
9. Germantown drug company hires pharma veteran James Davidson as COO
10. Georgia stem cell company likely to stay put
11. Surgical products company wins Governors Business Plan Contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2010)... Stock Exchange Symbol: MS , ... , , ... ... EDMONTON , March 16 ... ...
(Date:3/16/2010)... PharmAthene, Inc. (Amex: PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results ... ... , ... ... ...
(Date:3/16/2010)... March 16 The Gynecologic Cancer Foundation (GCF) and the Claudia ... as the first recipient of the $50,000 GCF/Claudia Cohen Prize for Outstanding ... (SGO) 41st Annual Meeting on Women,s Cancer, meeting in San Francisco ... ... ...
(Date:3/16/2010)... (LSE: SHP,NASDAQ; SHPGY), announces that it has received a Paragraph IV Notice ... New Drug Application ("ANDA") for a generic version of Shire,s 1,mg, 2mg, ... ... ... , ...
Breaking Biology Technology:BioMS Medical Announces 2009 Year End Results 2BioMS Medical Announces 2009 Year End Results 3BioMS Medical Announces 2009 Year End Results 4BioMS Medical Announces 2009 Year End Results 5BioMS Medical Announces 2009 Year End Results 6BioMS Medical Announces 2009 Year End Results 7BioMS Medical Announces 2009 Year End Results 8BioMS Medical Announces 2009 Year End Results 9BioMS Medical Announces 2009 Year End Results 10PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 2PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 3Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 2Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 3Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 4Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 5Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 2Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 3Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 4
... off marginally legal fireworks, I was feeling a little guilty. ... phone was powered off most of the weekend. Here it ... felt anything but independent of my technologies. , ,Ignoring e-mail ... comes with a penalty of sorting through an over-loaded inbox, ...
... is becoming increasingly important as businesses seek to protect ... built up as a result of the business' products ... trademark registration are filed, many of them for federal ... by some as a good leading indicator of economic ...
... Wis. The National Institutes of Health ... $4 million Fast-Track SBIR grant from the National ... , ,Under this grant, Stratatech will work to ... with enhanced antimicrobial and angiogenetic properties for use ...
Other Biology Technology:Declaring independence from technology (sort of) 2Declaring independence from technology (sort of) 3Why file for trademark protection? 2Why file for trademark protection? 3Why file for trademark protection? 4
(Date:3/18/2010)... can live for twenty years, fertilizing millions of eggs ... activity. , Danish researchers who have studied ants ... 1992 discovered that in both ant and bee species ... fluid favors the survival of its own sperm over ... stored, leafcutter ant queens neutralize male-male sperm competition with ...
(Date:3/18/2010)... available in Spanish . , Feeding ... as part of their regular diet makes them ... a study by Agricultural Research Service (ARS) scientists ... and overall behavioral activity among young female pigs ... acquired through diet, is the precursor for the ...
(Date:3/18/2010)... Biotech, Inc., ( www.genwaybio.com ) the US-based diagnostic company ... is expanding this cancer testing program internationally. An ... YouTM Cancer Assessment in Greece starting in April. ... as well. GenWay currently offers this test in ... Sergey Sikora, Vice President of Business Development, said, "The ...
Breaking Biology News(10 mins):Females shut down male-male sperm competition in leafcutter ants 2Tryptophan-enriched diet reduces pig aggression 2Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 1Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 2Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 1Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 2Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 1Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 2Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 3
... this week in the online early edition of the ... finds that coal burning, primarily in North America and ... and ecosystems in and around Earth,s polar regions. , ... Legacy in the Arctic," was conducted by the Desert ...
... distribution, of smartTOUCH(TM) consumer products into South Africa and ... ... JERICHO, N.Y., Aug. 18 bioMETRX Inc., (OTC,Bulletin Board: BMRX), ... Sequiam Corporation have been transferred to bioMETRX,S.A. at the request of ...
... Computing program has awarded $10 million to the Molecular ... California Institute of Technology and the University of Washington ... complex molecular and chemical systems based on the principles ... study, molecular programs, are collections of molecules that may ...
Other Biology News:Greenland ice core reveals history of pollution in the Arctic 2bioMETRX, Inc. Acquires Assets of Sequiam Biometrics (Pty) Ltd. 2bioMETRX, Inc. Acquires Assets of Sequiam Biometrics (Pty) Ltd. 3Caltech researchers awarded $10M for molecular programming project 2
... Time-resolved microscopy is the ultimate tool ... subcellular structures. Its applications previously have been ... because microscope optics do not transmit in ... leader in fluorescence spectroscopy, introduces a filter-based ...
... using many of the automation concepts from ... requirements are similar to those for HTS: ... 24 or 48 wells with well volumes ... the number of wells has increased to ...
... Dermal Fibroblasts (Mouse/BalbC) and media. This cell ... and is guaranteed to provide an additional ... date supplied, when used with the recommended ... 18.5 ,Applications: ,Cultivation: Plate at ...
... Sphingobeads are designed for protein ... characterize sphingosine binding proteins. An ... mL of agarose beads with ... through the terminus of the ...
Biology Products: